Posted on:
10/06/2017

In our Snapshots blog series, we turn to Maine Cancer Foundation constituents - from staff, board members and other volunteers, donors, grant recipients and beyond - to share important moments in their lives related to cancer. Our series will paint a broad stroke of the cancer landscape in the state, while narrowing the focus into the rare and intimate moments that bring us all together.

Snapshots #6 is the story of Maine Cancer Foundation’s Event Manager, Julia Bachelder. At 23 she found out she was a BRCA 2 carrier, she shares how she navigates through her journey.
---

“My grandfather died of breast cancer,” said Julia Bachelder, Maine Cancer Foundation’s Events Manager. Growing up, I knew he’d passed away from cancer, but it wasn’t until I was an adult that I learned he’d had breast cancer. Statistically, women are more likely to be diagnosed with breast cancer, but genetics play a large role in the diagnosis of men. “My dad asked my sister if we wanted him to be tested [for the breast cancer gene],” she reflected. “Some people want to know and some people don’t.” Julia and her sister asked her father to be tested, and they learned he was a carrier.

Posted on:
09/21/2017

For this month's Challenge Cancer 2020 package, our partners at WMTW-TV interview Maine Cancer Foundation grantee, Dr. Paul Han with Maine Medical Center, and Terry Kunjel with Maine Coalition to Fight Prostate Cancer.  

For the month of September Maine Cancer Foundation is focusing on men's health and prostate cancer.  Shared decision making is critical to patient centered health care and can lead to a healthier Maine.  

#togetherwecan #challengecancer2020

 

Posted on:
09/12/2017

In our Snapshots blog series, we turn to Maine Cancer Foundation constituents - from staff, board members and other volunteers, donors, grant recipients and beyond - to share important moments in their lives related to cancer. Our series will paint a broad stroke of the cancer landscape in the state, while narrowing the focus into the rare and intimate moments that bring us all together.

Snapshots #6 is the story of Jon Henry, who was diagnosed with prostate cancer at just 44 years old. His treatment caused life-altering side effects, but even in the midst of challenges, Jon found camaraderie and healing. 

--

Posted on:
09/07/2017

While cancer can seem scary, there are things we can do to lower our risk. This month, Maine Cancer Foundation is discussing men's health. Enjoy this helpful infographic from our colleagues at the American Institute for Cancer Research:

Posted on:
09/06/2017

Paul Han, MD, MA, MPH, is the Director of the Center for Outcomes Research and Evaluation at Maine Medical Center Research Institute. In June 2016, Maine Cancer Foundation awarded Maine Medical Center a $400,000 grant over four years for The Maine Lung Cancer Prevention and Screening (Maine LungCAPS) InitiativeMaine LungCAPS is a multi-institution, multi-disciplinary collaboration of Maine health care providers and stakeholders. Dr. Han serves as Principal Investigator for the initiative, designed to improve the prevention, early detection and treatment of lung cancer in Maine

The month of September is dedicated to men’s health and prostate cancer. In our guest blog series, Dr. Han shares his opinions about the prostate-specific antigen (PSA) test, a blood test used to screen for prostate cancer.

--

Prostate cancer is the most common cancer and the third leading cause of cancer deaths among US men.  The prostate-specific antigen (PSA) test is a blood test used to “screen” for prostate cancer—that is, to detect cancer at an early stage, when it can be effectively treated.  PSA testing is currently the only available screening test for prostate cancer, and for many years it has been widely used. 

PSA screening has also been controversial.  It’s not a perfect test because it misses some cancers (leading to false reassurance), and can also produce false-positive results (“false alarms”), which can lead to unnecessary anxiety and prostate biopsy procedures.  And although prostate cancer can be aggressive and lethal, many of the cancers detected by the PSA test will never grow, spread, or cause additional problems. 

Pages